Other news
![RTM supports Citryll’s imaging trial of [89Zr]Zr-DFO-CIT-013](https://radboudtranslationalmedicine.nl/cdn/42251bd5-d9e6-4107-bbd7-ac13f0c8609a/-/smart_resize/250x170/-/format/auto/-/quality/smart/citryll-cityview-combined-logo.png){kind=logo}
RTM supports Citryll’s imaging trial of [89Zr]Zr-DFO-CIT-013
Radboud Translational Medicine (RTM) is proud to announce its role as manufacturing partner for the...
ABX has received marketing authorisation for the radiotracer Radelumin® in Germany
ABX has received marketing authorisation for the radiotracer Radelumin® in Germany! This marks the 8...
RTM receives marketing authorisation for Fludeoxyglucose (18F)
We are happy to announce that RTM has received marketing authorization for 18F-FDG of 17 July 2018....
Upcoming event
From October 15 to October 19, Radboud translational medicine will attend the 29th annual congress o...
Interested in a collaboration?
Contact us to discuss the possibilities.